Labeling Guidance Asks For Too Much Detail On Dosage & Administration – PhRMA
Executive Summary
The amount of information to be included in the Dosage and Administration section of labeling under a recent draft guidance may be too detailed for certain drug products, the Pharmaceutical Research and Manufacturers of America say in comments submitted on the draft